BNGO vs. PFE

Last updated Jun 4, 2026

BNGO (Bionano Genomics, Inc.) and PFE (Pfizer Inc.) are both stocks. Both are in the Healthcare sector — BNGO in Diagnostics & Research, PFE in Drug Manufacturers - General. Over the past 5 years, BNGO returned -80.06%/yr vs -3.51%/yr for PFE. At a 0.13 correlation, their price movements are largely independent.

Performance

BNGO vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bionano Genomics, Inc. (BNGO) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BNGO achieves a -15.03% return, which is significantly lower than PFE's 5.18% return.

BNGO

• 1D: 3.17%
• 1M: 4.84%
• YTD: -15.03%
• 6M: -24.86%
• 1Y: -64.77%
• 3Y*: -86.03%
• 5Y*: -80.06%
• 10Y*: —

PFE

• 1D: -0.82%
• 1M: -2.06%
• YTD: 5.18%
• 6M: 2.42%
• 1Y: 16.11%
• 3Y*: -7.32%
• 5Y*: -3.51%
• 10Y*: 1.85%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BNGO vs. PFE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
BNGO Bionano Genomics, Inc.	-15.03%	-91.16%	-84.74%	-87.05%	-51.17%	-2.92%	148.39%	-76.34%	-25.04%
PFE Pfizer Inc.	5.18%	0.65%	-2.22%	-41.26%	-10.41%	66.70%	3.07%	-6.91%	-0.17%

Correlation

The correlation between BNGO and PFE is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (All Time) Calculated using the full available price history since Sep 24, 2018	0.13

The correlation between BNGO and PFE shifts across timeframes, from 0.13 (all time) to 0.24 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS BNGO : -$6.55 PFE : $1.31
PS Ratio BNGO : 0.21 PFE : 2.28
Total Revenue (TTM) BNGO : $22.06M PFE : $63.32B
Gross Profit (TTM) BNGO : $3.32M PFE : $43.91B
EBITDA (TTM) BNGO : -$23.09M PFE : $16.94B

Return for Risk

BNGO vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNGO

BNGO Risk / Return Rank: 11
BNGO Sharpe Ratio Rank: 9
BNGO Sortino Ratio Rank: 10
BNGO Omega Ratio Rank: 8
BNGO Calmar Ratio Rank: 9
BNGO Martin Ratio Rank: 18

PFE

PFE Risk / Return Rank: 61
PFE Sharpe Ratio Rank: 62
PFE Sortino Ratio Rank: 57
PFE Omega Ratio Rank: 55
PFE Calmar Ratio Rank: 67
PFE Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNGO vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bionano Genomics, Inc. (BNGO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BNGO	PFE	Difference
Sharpe ratio Return per unit of total volatility	-0.80	0.68	-1.48
Sortino ratio Return per unit of downside risk	-1.09	1.18	-2.27
Omega ratio Gain probability vs. loss probability	0.83	1.14	-0.31
Calmar ratio Return relative to maximum drawdown	-0.83	1.41	-2.24
Martin ratio Return relative to average drawdown	-1.08	2.91	-3.99
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BNGO vs. PFE - Sharpe Ratio Comparison

The current BNGO Sharpe Ratio is -0.80, which is lower than the PFE Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of BNGO and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BNGO	PFE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.80	0.68	-1.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.89	-0.14	-0.75
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.08	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.34	0.23	-0.57

Drawdowns

BNGO vs. PFE - Drawdown Comparison

The maximum BNGO drawdown since its inception was -99.99%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BNGO and PFE.

Drawdown Indicators

	BNGO	PFE	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-58.96%	-41.03%
Max Drawdown (1Y) Largest decline over 1 year	-77.85%	-11.47%	-66.38%
Max Drawdown (3Y) Largest decline over 3 years	-99.76%	-40.75%	-59.01%
Max Drawdown (5Y) Largest decline over 5 years	-99.98%	-58.96%	-41.02%
Max Drawdown (10Y) Largest decline over 10 years	—	-58.96%	—
Current Drawdown Current decline from peak	-99.99%	-47.49%	-52.50%
Average Drawdown Average peak-to-trough decline	-83.70%	-17.68%	-66.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.12%	5.54%	+54.58%

Volatility

BNGO vs. PFE - Volatility Comparison

Bionano Genomics, Inc. (BNGO) has a higher volatility of 11.64% compared to Pfizer Inc. (PFE) at 4.07%. This indicates that BNGO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BNGO	PFE	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.64%	4.07%	+7.57%
Volatility (6M) Calculated over the trailing 6-month period	45.02%	14.64%	+30.38%
Volatility (1Y) Calculated over the trailing 1-year period	81.10%	23.85%	+57.25%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	90.54%	25.49%	+65.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	191.66%	23.88%	+167.78%

Dividends

BNGO vs. PFE - Dividend Comparison

BNGO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.79%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BNGO Bionano Genomics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PFE Pfizer Inc.	6.79%	6.91%	6.33%	5.70%	3.12%	2.64%	3.92%	3.68%	3.12%	3.53%	3.69%	3.47%

Financials

Frequently Asked Questions

Can I hold both BNGO and PFE in my portfolio?

BNGO and PFE have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BNGO or PFE?

BNGO has higher volatility (11.64%) compared to PFE (4.07%). In terms of maximum drawdown, BNGO dropped -99.99% vs PFE's -58.96%.

Which has better risk-adjusted returns?

PFE currently has the higher Sharpe Ratio (0.68 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.